TR199900506T2 - Yeni y�ntemler. - Google Patents

Yeni y�ntemler.

Info

Publication number
TR199900506T2
TR199900506T2 TR1999/00506T TR9900506T TR199900506T2 TR 199900506 T2 TR199900506 T2 TR 199900506T2 TR 1999/00506 T TR1999/00506 T TR 1999/00506T TR 9900506 T TR9900506 T TR 9900506T TR 199900506 T2 TR199900506 T2 TR 199900506T2
Authority
TR
Turkey
Prior art keywords
new methods
idoxy
women
post
treatment
Prior art date
Application number
TR1999/00506T
Other languages
English (en)
Turkish (tr)
Inventor
N. Bradbeer Jeremy
Gowen Maxime
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of TR199900506T2 publication Critical patent/TR199900506T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TR1999/00506T 1996-09-06 1997-09-03 Yeni y�ntemler. TR199900506T2 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2543996P 1996-09-06 1996-09-06
US5066697P 1997-06-24 1997-06-24

Publications (1)

Publication Number Publication Date
TR199900506T2 true TR199900506T2 (xx) 1999-07-21

Family

ID=26699738

Family Applications (2)

Application Number Title Priority Date Filing Date
TR1999/00504T TR199900504T2 (xx) 1996-09-06 1997-09-03 Osteoporoz dahil olmak �zere menopoz sonras� hastal�klar�n tedavi y�ntemi
TR1999/00506T TR199900506T2 (xx) 1996-09-06 1997-09-03 Yeni y�ntemler.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR1999/00504T TR199900504T2 (xx) 1996-09-06 1997-09-03 Osteoporoz dahil olmak �zere menopoz sonras� hastal�klar�n tedavi y�ntemi

Country Status (16)

Country Link
EP (2) EP0927029A4 (no)
JP (2) JP2002515046A (no)
KR (2) KR20000068472A (no)
CN (2) CN1236299A (no)
AR (1) AR008155A1 (no)
AU (2) AU4247397A (no)
BR (2) BR9711676A (no)
CA (2) CA2264943A1 (no)
CO (2) CO4920218A1 (no)
CZ (1) CZ76699A3 (no)
IL (1) IL128645A0 (no)
NO (2) NO991097L (no)
PL (2) PL332278A1 (no)
TR (2) TR199900504T2 (no)
TW (1) TW411273B (no)
WO (2) WO1998009519A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998034608A1 (en) * 1997-02-11 1998-08-13 Novo Nordisk A/S Methods for treatment or prophylaxis of menopausal symptoms
GB9827121D0 (en) * 1998-12-09 1999-02-03 Orion Corp Agent for lowering endothelin levels
DE19905961A1 (de) * 1999-02-12 2000-08-17 Stefan Neubauer Verwendung von Östrogenen zur Behandlung der Herzinsuffizienz
US6528681B2 (en) * 2000-04-05 2003-03-04 Bristol-Meyers Squibb Pharma Company Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
TWI303990B (en) 2000-10-17 2008-12-11 Pfizer Prod Inc New use of estrogen agonists/antagonists for improving vascular health

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260066B1 (en) * 1986-09-11 1990-05-09 National Research Development Corporation Tamoxifen derivatives
DE69316633T2 (de) * 1992-09-15 1998-05-20 Merrell Dow Pharma Nichtmetabolisierbare clomiphene-analoge zur behandlung von tamoxifen-resistenten tumoren
US5681835A (en) * 1994-04-25 1997-10-28 Glaxo Wellcome Inc. Non-steroidal ligands for the estrogen receptor
US5604248A (en) * 1994-05-05 1997-02-18 Eli Lilly And Company Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
US5470883A (en) * 1994-05-23 1995-11-28 Stromberg; Brent V. Method of treating peripheral vasoconstriction with tamoxifen citrate
JPH11510479A (ja) * 1995-06-07 1999-09-14 ネオルックス コーポレイション タモキシフェン類似体による心臓血管疾病の予防及び治療
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6069175A (en) * 1996-11-15 2000-05-30 Pfizer Inc. Estrogen agonist/antagonists treatment of atherosclerosis

Also Published As

Publication number Publication date
KR20000068473A (ko) 2000-11-25
AU4247397A (en) 1998-03-26
NO991096L (no) 1999-03-05
CA2264943A1 (en) 1998-03-12
PL332038A1 (en) 1999-08-16
NO991097D0 (no) 1999-03-05
AR008155A1 (es) 1999-12-09
TW411273B (en) 2000-11-11
BR9711676A (pt) 1999-08-24
NO991097L (no) 1999-03-05
JP2002515046A (ja) 2002-05-21
WO1998009519A1 (en) 1998-03-12
NO991096D0 (no) 1999-03-05
IL128645A0 (en) 2000-01-31
JP2002515047A (ja) 2002-05-21
AU4409797A (en) 1998-03-26
BR9711681A (pt) 1999-08-24
EP0929216A4 (en) 2001-04-04
EP0927029A1 (en) 1999-07-07
CA2264775A1 (en) 1998-03-12
CZ76699A3 (cs) 1999-08-11
CO4920218A1 (es) 2000-05-29
EP0929216A1 (en) 1999-07-21
CN1236299A (zh) 1999-11-24
PL332278A1 (en) 1999-08-30
TR199900504T2 (xx) 1999-06-21
EP0927029A4 (en) 2001-06-13
KR20000068472A (ko) 2000-11-25
CO5070658A1 (es) 2001-08-28
CN1236313A (zh) 1999-11-24
WO1998009619A1 (en) 1998-03-12

Similar Documents

Publication Publication Date Title
EA199700170A1 (ru) Способ получения некоторых азациклогексапетидов
ATE239465T1 (de) Verwendung von 2,7,8-trimethyl-2-( beta- carboxyethyl )-6-hydroxy-chroman (llu-alpha)
IL132797A0 (en) Compounds and methods for the inhibition of the expression of vcam-1
EP1012795A4 (en) METHODS FOR MEASURING THE FLACCIDITY OF BANK NOTES
DE69722681D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen
BG101966A (en) Application of 1l-agonist for the treatment of lack of urine retention
DE69701346T2 (de) Verwendung von siliciumhaltigen Verbindungen zum Färben von Menschlichen Keratinfasern; neue Verbindungen und Zusammensetzungen, die diese enthalten.
DK0842169T3 (da) Benzothiophenforbindelser
ATE221763T1 (de) Die verwendung von glyceryltriacetat zur behandlung von onychomykosen
DE69623070T2 (de) Verbesserungen bezüglich der Sammlung von Prozesseluat
TR199900506T2 (xx) Yeni y�ntemler.
DZ2292A1 (fr) Méthode concernant l'immortalité des cellules.
ATE243036T1 (de) Levobupivacain und dessen verwendung als anästhetikum bei schwangeren frauen
PL318213A1 (en) Method of obtaining 3-(methylothio) propanal
EP0841933A4 (en) BOWMAN BIRK INHIBITOR COMPOSITIONS FOR TREATING INFLAMMATORY DISEASES
IL74191A0 (en) Method and kit for determining periodontal disease
BG97851A (en) Hard dosed forms of almocalante and method for obtaining them
KR950024522U (ko) 부인용 위생좌대
DE69526156D1 (de) Verwendung des 1,3-Undecadien-5-yne als Duftstoff
IL116168A0 (en) Kit for cycle of treatment of osteoporosis
DE3369732D1 (en) Method of determination of human urine kallikrein and kit for the same
SE9300735L (sv) Startblock
TR199801494T2 (xx) Vinil s�lfoksitler ve sentezlenmeleri i�in bir i�lem.
ZA967962B (en) Method for determining the ovulation period of fertile women.
IT1306494B1 (it) Intonaco per il contenimento dell'umidita' risalente nelle muraturee per il risanamento dei setti in c.a.